Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity

Arianna Dondi1, Salvatore Tripodi, Valentina Panetta

  • 1Pediatric Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Pediatric Unit, Department for Mother and Child, Ramazzini Hospital, Carpi, Italy.

Insights

Pollen-induced allergic rhinoconjunctivitis (AR) is common in Italian children, with over half experiencing moderate to severe symptoms. Longer AR duration correlates with increased symptom severity and comorbidities like asthma.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Allergies
  • Public Health

Background:

  • Pollen-induced allergic rhinoconjunctivitis (AR) is a prevalent childhood condition.
  • General practitioners may underestimate AR severity, delaying diagnosis and intervention.
  • Early diagnosis and intervention are crucial for managing childhood AR.

Purpose of the Study:

  • To assess the severity of pollen-induced AR in Italian children.
  • To identify determinants of AR severity in this population.
  • To evaluate children who have never received specific immunotherapy (SIT).

Main Methods:

  • Recruited 1360 children (4-18 years) with pollen-induced AR across 14 Italian cities.
  • Utilized standardized questionnaires and skin-prick tests (SPT) for allergen sensitization.
  • Collected data on demographics, family history, and early-life environmental exposures via the AllergyCARD™ platform.

Main Results:

  • 51% of children had moderate-to-severe AR; 39% had asthma, 23.9% had oral allergy syndrome (OAS).
  • Average AR onset at 5.3 years, with a mean duration of 5.2 years.
  • Longer AR duration was significantly linked to moderate-to-severe AR, asthma, and OAS (p < 0.001).

Conclusions:

  • Highlights the significant severity of pollen-induced AR in Italian children.
  • Emphasizes the association between AR duration and disease severity markers.
  • Recommends nationwide initiatives for earlier diagnosis and intervention in pediatric AR.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
Allergic Reactions02:06

Allergic Reactions

Overview
26.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K